Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Pan Pantziarka
Institutions:
Sarcoma Foundation of America,
Anticancer Fund
Observed institutions:
Sarcoma Foundation of America,
Anticancer Fund
ORCID:
0000-0002-4676-7835
Observed ORCID:
0000-0002-4676-7835
OpenAlex ID:
A5129809295
Defining a comprehensive set of value assessment criteria for funders of drug repurposing initiatives
2026
·
Dalma Hosszú
, Kristóf Gyöngyösi
, et al.
·
British Journal of Clinical Pharmacology
PDF
Pain in epithelioid hemangioendothelioma: Development of disease-specific pain assessment criteria (PAC-E)
2026
·
Luca Zambelli
, Ernesto Zecca
, et al.
·
European Journal of Cancer
PDF
Reply to ‘Stimulating medicines repurposing in the EU: a pilot project’
2026
·
Pan Pantziarka
, Patricia Vandamme
, et al.
·
Nature Reviews Drug Discovery
Sulfonylureas beyond diabetes: A comprehensive review on anticancer and off-target effects (1956–2025)
2026
·
Mateusz D. Tomczyk
, Claudia Wawrzynosek
, et al.
·
European Journal of Medicinal Chemistry
Show more works
View as search
Works count:
6
Citation count:
H-index:
I10-index:
Year
Topic
Type
